["{\n\"step_by_step_thinking\": \"None of the provided documents address the specific question of whether prior benign prostate biopsy predicts outcome for patients treated with radical perineal prostatectomy. The first document discusses the effect of transurethral resection of prostate (TURP) on treatment outcome, but not the predictive value of benign prostate biopsy. The second and third documents discuss the diagnosis and treatment of prostatic carcinoma, but do not address this specific question. The fourth document presents a method for measuring prostate-specific antigen (PSA), which is used as a biomarker in the diagnosis and monitoring of prostatic cancer, but does not provide information on the predictive value of prior benign prostate biopsy.\",\n\"answer_choice\": \"B\""]